dual-antiplatelet therapy

Original Contribution

Initial Experience of Bioabsorbable Polymer Everolimus-Eluting Synergy Stents in High-Risk Patients Undergoing Complex Percutaneous Coronary Intervention With Early Discontinuation of Dual-Antiplatelet Therapy

12/15/2016

Colm G. Hanratty , MD;

Simon J. Walsh , MD;

;

Synergy stents (Boston Scientific) allow for early cessation of DAPT. This study assessed those in our unit who underwent PCI with a Synergy stent to examine a minimum of 6 months of clinical outcomes after early discontinuation of DAPT.

Synergy stents (Boston...

12/15/2016

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

March 23 ⁠–⁠ March 24

April 27 ⁠–⁠ April 28

Great Debates & Updates in Diabetic Foot

November 30 ⁠–⁠ December 2

November 27 ⁠–⁠ November 29

December 12 ⁠–⁠ December 13

May 13 ⁠–⁠ May 14

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

dual-antiplatelet therapy

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products